Global Image-Guided Therapy System Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Product;

Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI), Endoscopes, Positron Emission Tomography (PET), and Others.

By Application;

Neurosurgery, Cardiac Surgery, Urology, Orthopedic Surgery, and Others.

By End-User;

Hospitals, Ambulatory Surgery Centers, and Clinics.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn661884949 Published Date: April, 2024 Updated Date: May, 2024

Introduction

Global Image-Guided Therapy System Market (USD Million), 2020 - 2030

In the year 2023, the Global Image-Guided Therapy System Market was valued at USD 2,929.26 million. The size of this market is expected to increase to USD 4,177.03 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 5.2%.

The global market for Image-Guided Therapy (IGT) systems is expanding rapidly due to technological advancements and the growing acceptance of minimally invasive medical procedures. Image-guided therapy systems combine real-time imaging technologies like CT scans, MRI, ultrasound, and fluoroscopy with therapeutic interventions to enable precise targeting of treatment areas within the body. These systems provide healthcare providers with enhanced visualization capabilities, allowing them to perform complex procedures with greater accuracy while minimizing risks for patients. The market includes a diverse array of devices and solutions tailored for various medical specialties, including cardiology, oncology, neurology, and orthopedics.

Several key factors are driving the growth of the global Image-Guided Therapy (IGT) system market. These include the increasing prevalence of chronic diseases, the shift towards personalized medicine, and advancements in medical imaging technologies. As the incidence of complex medical conditions rises globally, there is a growing demand for minimally invasive therapies that offer faster recovery times, fewer complications, and improved patient outcomes. Image-guided therapy systems empower healthcare providers to precisely deliver treatments to specific areas, minimizing damage to surrounding healthy tissues and optimizing treatment effectiveness.

Geographically, the global Image-Guided Therapy (IGT) system market encompasses regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, each with unique market dynamics and adoption rates. Developed regions like North America and Europe lead in IGT system adoption due to well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced medical technologies. In contrast, emerging economies in Asia Pacific and Latin America are experiencing rapid growth in IGT system adoption driven by increasing investments in healthcare infrastructure, rising disposable incomes, and growing awareness of the benefits of minimally invasive therapies. With ongoing technological innovations shaping medical practices, the global Image-Guided Therapy system market is poised for significant expansion and innovation to meet evolving healthcare needs worldwide.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Application
    3. Market Snapshot, By End-User
    4. Market Snapshot, By Region
  4. Global Image-Guided Therapy System Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers:
        1. Technological Advancements
        2. Rising Prevalence of Chronic Diseases
        3. Growing Preference for Minimally Invasive Procedures
      2. Restraints:
        1. High Costs of Equipment and Procedures
        2. Complex Regulatory Environment
        3. Limited Access to Skilled Professionals
      3. Opportunities:
        1. Expansion of Applications Across Medical Specialties
        2. Advancements in Artificial Intelligence (AI) and Robotics
        3. Increasing Healthcare Investments in Emerging Markets
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Image-Guided Therapy System Market, By Product, 2020 - 2030 (USD Million)
      1. Ultrasound Systems
      2. Computed Tomography (CT) Scanners
      3. Magnetic Resonance Imaging (MRI)
      4. Endoscopes
      5. Positron Emission Tomography (PET)
      6. Others
    2. Global Image-Guided Therapy System Market, By Application, 2020 - 2030 (USD Million)
      1. Neurosurgery
      2. Cardiac Surgery
      3. Urology
      4. Orthopedic Surgery
      5. Others
    3. Global Image-Guided Therapy System Market, By End-User, 2020 - 2030 (USD Million)
      1. Hospitals
      2. Ambulatory Surgery Centers
      3. Clinics
    4. Global Image-Guided Therapy System Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Koninklijke Philips N.V.
      2. Analogic Corporation
      3. Brainlab
      4. GE Healthcare
      5. Siemens Healthineers
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Imatinib Drug
Global Imatinib Drug Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Imatinib Drug Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Immortalized Cell Line
Global Immortalized Cell Line Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Immortalized Cell Line Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Immune Thrombocytopenia (ITP)
Global Immune Thrombocytopenia (ITP) Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Immune Thrombocytopenia (ITP) Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Immuno-Oncology Therapy
Global Immuno-Oncology Therapy Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Immuno-Oncology Therapy Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...